Refine by
Stent Thrombosis Equipment & Supplies In Austria
12 equipment items found
Manufactured by:Becton Dickinson and Company (BD) based inFranklin Lakes, NEW JERSEY (USA)
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late stent thrombosis with current DESs. In addition, Tepha is developing fully absorbable polymer stents containing ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. and effective across a broad spectrum of patient and lesion complexity. ...
Manufactured by:Medinol based inTel Aviv, ISRAEL
From crimping through delivery through calcified lesions, expansion and drug elution, drug-eluting stents endure substantial mechanical and chemical stress. Inherently brittle, traditional polymer coatings of drug eluting stents have been shown to develop surface imperfections and deformations, which under stress can crack and even peel away from the stent • Such cracking and peeling can ...
Manufactured by:amg International GmbH based inWinsen, GERMANY
The ITRIXII Sirolimus-Eluting Coronary Stent Implantation System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Sirolimus (Rapasorb™) as a highly effective drug for preventing thrombotic and re-stenotic ...
Manufactured by:Tsunamed, Part of Q3 Medical Group based inWinsen, GERMANY
The MAGMA Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) as a highly effective drug for preventing thrombotic and re-stenotic ...
Manufactured by:Stron Medical, Part of Q3 Medical Group based inWinsen, GERMANY
The GALAXY Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) as a highly effective drug for preventing thrombotic and re-stenotic ...
Manufactured by:Translumina GmbH based inHechingen, GERMANY
The Translumina Yukon drug-eluting stent product family, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical ...
Manufactured by:Translumina GmbH based inHechingen, GERMANY
The Translumina Yukon Choice PC drug-eluting stent, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical ...
Manufactured by:Abbott Laboratories based inAbbott Park, ILLINOIS (USA)
Precision. Performance. Results. Excellent precision, flexibility and proven clinical results in the iliacs. Precision; Triaxial technology designed to absorb stored energy and minimize friction during deployment to ensure precise stent ...
Manufactured by:Arterius Limited based inLeeds, UNITED KINGDOM
ArterioSorb is produced from the FDA approved polymer, PLLA, which is already universally approved for use in cardiovascular stents, sutures and orthopaedic applications. ArterioSorb is a tubular stent with closed-cell (with connectors for strength) and open-cell (with fewer connectors for flexibility) modules and increasing cell size as one moves away from the centre: The smaller cells at the ...
Manufactured by:CeloNova BioSciences, Inc. based inCarlsbad, CALIFORNIA (USA)
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular ...